Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
144
Publications avec texte intégral
Open Access
53 %
Mots clés
Transcriptomics
Maximal force
Gene editing
Autophagy
Mouse model
Myotonic Dystrophy Type 1
Genotype phenotype correlation
KNOCKOUT MICE
Heart failure
AAV
Myostatin
Cultured
DM1
Myelin
DMSXL mice
Myotonic Dystrophy
Glucocorticoids
Duchenne muscular dystrophy
Male
PCR
Thérapie génique
CMS
Dystrophin
Hypoxia
Transgenic mouse model
Motoneuron
Myotonic Dystrophy type 1
GSK3
Myotonic dystrophy
Quantitative microdialysis
Trinucleotide Repeat Expansion
Exercice
Astrocyte
Aging
Cardiac muscle
PacBio
Antisense oligonucleotide
Desmin
Cell model
Muscular dystrophy
Dynamin 2
Exercise
RNA biology
DMPK
Acute coronary syndrome
Cell penetrating peptide
Acetylcholinesterase deficiency
ACETYLCHOLINESTERASE
Neuron
Myotonic dystrophy mouse models
Therapy
Dilated cardiomyopathy
Fibrosis
Acetylcholinesterase knockout mouse
Oligodendrocytes
Gene therapy
Glial cells
CTG repeat instability
CRISPR/Cas9
Glucocorticoid-receptor
Alternative splicing
Brain dysfunction
Dystrophie myotonique
CTG repeats
Astrocytes
Brain
ARN
BIOLOGIE MOLECULAIRE
Cytoskeleton
MBNL
CRISPRi
Myotonic dystrophy type 1
Oligodendrocyte
Expression
CTG repeat contractions
Humans
GABA
Gene Therapy
Cell culture model
Muscle
Endurance training
Centronuclear myopathy
Mice
Diaphragm
Antisense oligonucleotides
Mouse models
Glutamate
RNA splicing
Dystrophie Myotonique
Heart
Skeletal muscle
Intermediate filament
CONGENITAL MYATHENIC SYNDROME
Transgenic mouse
Animals
Trinucleotide repeat expansion
Central nervous system
Cells
Long read sequencing
RNA interference